Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone ...

Researchers have developed a new compound, ZTA-261, that binds to thyroid hormone receptor beta (THR ). THR plays an important role in the regulation of lipid metabolism, which affects lipid levels in ...

New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and ...

The early funding will help transition its research into scalable therapies targeting lysosomal storage disorders.

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general ...

Please provide your email address to receive an email when new articles are posted on . The FDA extended its approval of alirocumab to treat a genetic lipid disorder in patients as young as 8 years.

A team of medics performing CPR and inserting an IV drip on a patient lying unconscious in a hospital bed. [iStockphoto] When 19-year-old *Jeffrey walked into Aga Khan Hospital after suffering a heart ...

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children. This recommendation statement was first published in ...

Researchers have developed a new lipid nanoparticle design that directs mRNA to the pancreas by exploiting the organ’s own ...

Scientists have identified the transporter protein that allows essential fats in the bloodstream to enter the skin, reshaping ...